Abstract
ABSTRACTThe escalating adoption of Next Generation Sequencing (NGS) in clinical diagnostics reveals genetic variations, termed secondary findings (SFs), with health implications beyond primary diagnoses. The Collaborative Spanish Variant Server (CSVS), a crowdsourced database, contains genomic data from more than 2100 unrelated Spanish individuals. Following the American College of Medical genetics (ACMG) guidelines, CSVS was analyzed, identifying pathogenic or likely pathogenic variants in 78 actionable genes (ACMG list v3.1) to ascertain SF prevalence in the Spanish population. Among 1129 samples, 60 reportable SFs were found in 5% of individuals, impacting 32 ACMG-listed genes, notably associated with cardiovascular disease (59.4%), cancer (25%), inborn errors of metabolism (6.3%), and other miscellaneous phenotypes (9.4%). The study emphasizes utilizing dynamic population databases for periodic SF assessment, aligning with evolving ACMG recommendations. These findings illuminate the prevalence of significant genetic variants, enriching understanding of secondary findings in the Spanish population.
Publisher
Cold Spring Harbor Laboratory
Reference53 articles.
1. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions;Genetics in Medicine,2022
2. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes;Frontiers in genetics,2015
3. Miller DT , Lee K , Abul-Husn NS , Amendola LM , Brothers K , Chung WK , Gollob MH , Gordon AS , Harrison SM , Hershberger RE : ACMG SF v3. 1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). In., vol. 24: Elsevier; 2022: 1407–1414.
4. Opportunistic genomic screening. Recommendations of the European society of human genetics;European Journal of Human Genetics,2021
5. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing